10/12/2021CDE Solicits Comments on Draft Technical Guidance for Clinical Researc...

10/12/2021AZ Inaugurates Upgraded Global R&D China Center

10/12/2021Shanghai Pharma and Luca Healthcare Announce a Strategic Collaboration...

10/12/2021Hansoh and OliX Enter into Licensing Deal for siRNA Therapeutics in ...

10/12/2021Sutro and BioNova Enter into Collaboration for STRO-001 in Greater Chi...

10/12/2021Helsinn Signs CINV Drug Licensing Pact with Fosun Pharma

10/12/2021Reistone Announces Positive Results from a PII Study Evaluating SHR030...

10/11/2021CDE Solicits Comments on Draft Technical Guidance for Clinical Protoco...

10/11/2021Kintor Wins Chinese Approval for Clinical Trial of ALK-1/Nivolumab Com...

10/11/2021TRACON and Eucure Enter Partnership to Develop Clinical-stage CTLA-4 A...

10/11/2021Brii Biosciences Files Application for EUA for BRII-196/BRII-198 Thera...

10/11/2021Impact of Recent China Data Protection Laws on Asian Life Sciences Ind...

10/11/2021Asia Life Sciences - Navigating US-China Relations

10/11/2021Impact of the 2020 China Diabetes Society Guideline on the Prevalence ...

10/9/2021CDE Publicizes the List of Reference Formulations for GQCE Studies (50...

10/9/2021Recent Executive Moves

10/8/2021CDE Solicits Public Comments on the Technical Guidance on Clinical Pro...

10/6/2021Zai Lab Mulls China Filing for MacroGenics' HER2 Anticancer Margetuxim...

10/6/2021Anixa Biosciences Announces First Chinese Patent on its CAR-T Cancer T...

10/6/2021Nature: China's Data-driven Dream to Overhaul Healthcare

10/5/2021NH Reports MAT 06/2021 Data on the Chinese Cough, Cold and Allergy Mar...

10/5/2021Recent Developments with A New Round of NEDL Revision

10/4/2021China to Adopt Patient Reported Outcome Technology to Supplement Clini...

10/4/2021LianBio Files for IPO, Plans to Apply for Nasdaq Listing

10/4/2021Kintor Pharma Announces First Patient Dosing in Phase III Trial of Pro...

9/30/2021NMPA Applies for Pre-accession to PIC/S    

9/30/2021NMPA Issues the Announcement on eCTD Implementation

9/30/2021Financial-related Company News in Brief

9/30/2021Recent Executive Moves

9/30/2021Luye Pharma Granted Chinese IND Approval for Class 1 New Drug LY03015

Page:111/719 Total number of articles:21546: [First][<<] [109] [110] [111] [112] [113] [>>] [End]